PA
PR

PRO-spectus

Simplifying patient access to specialized therapies through integrated support, market access, and policy expertise.

Visit Website

Known For

PE-backed growth platform with top-tier experts

Key Differentiators

  • PE-backed growth platform with top-tier experts
  • US-based team using latest eServices/technology
  • Acts as extension of client's market access function, driving policy changes from patient level up

Overview

PRO-spectus provides integrated patient access solutions for life sciences companies, helping overcome reimbursement, coding, policy, and access barriers to connect specialized therapies with patients. They offer services across patient support, market access consulting, reimbursement optimization, and policy strategy, leveraging technology and expert teams for end-to-end support.

Services & Capabilities

  • Patient Support Services (insurance benefits navigation, prior authorization, supplier coordination)
  • Market Access consulting
  • Reimbursement Support and revenue cycle management (claims analysis, coding validation, credentialing)
  • Policy Strategy (medical/payor policy tactics)
  • Pharmacy services
  • C

Competitive Position

  • PE-backed growth platform with top-tier experts
  • US-based team using latest eServices/technology
  • Acts as extension of client’s market access function, driving policy changes from patient level up

Recent Developments

April 2024: Partnership with Shore Capital Partners for expansion Business Wire; 2025: Attending Informa Copay & Access Congress; hiring (Salesforce Architect); leadership podcasts; executive hires (e.g., Maximilian Klietmann, VP Market Access). No coverage in FiercePharma, Drug Channels, PM360, etc.

Client & Partner Ecosystem

Lumos Diagnostics; Shore Capital Partners (investor); anonymous Pharmaceutical / Biotech Manufacturers (testimonials)

Technology Platform

PRO-spectus Patient Access Program (eServices)

Therapeutic Focus

broad/all

Target Customers

Pharmaceutical companies, biotechs, medical device manufacturers, diagnostic firms

Sources